Please login to the form below

Not currently logged in
Email:
Password:

Auspex

This page shows the latest Auspex news and features for those working in and with pharma, biotech and healthcare.

Teva’s weak pipeline hit by Tourette’s drug trial failure

Teva’s weak pipeline hit by Tourette’s drug trial failure

Deutetrabenazine was acquired by Teva when it bought  Auspex Pharma for $3.5bn in March 2015.

Latest news

More from news
Approximately 1 fully matching, plus 8 partially matching documents found.

Latest Intelligence

  • Deal Watch May 2016 Deal Watch May 2016

    Teva's drug SD 809 for the treatment of Huntington's disease was part of the acquisition of Auspex at a cost of $3.5bn.

  • Medius Deal Watch table for March 2015 Medius Deal Watch table for March 2015

    21, 000. Auspex / Teva. Company acquisition. Phase 3 product for Huntington's Chorea deuterium technology platform.

  • Pharma deals in March 2015 Pharma deals in March 2015

    21.0. 43. 60%. Auspex. Teva. 3.5. No sales. 42%. Ikaria. Mallinckrodt. ... For example, this month Teva paid $3.5bn to acquire a loss-making company, Auspex Pharmaceuticals, with a pipeline of CNS products including one in phase III.

More from intelligence
Approximately 0 fully matching, plus 3 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Jet Off with Maloff Protect

Latest intelligence

Ludovic Helfgott
Novo Nordisk awakens its ‘Sleeping Beauty’
Biopharm emerges from troubled times to hit ‘solid growth’, says executive vice president Ludovic Helfgott...
How will the Tories’ historic win shape the NHS?
Paul Midgley and Oli Hudson, of Wilmington Healthcare, explore the impact of December’s General Election result on 2020 and beyond...
CSR 'Christmas Spirit' 2019
OPEN Health champions CSR over Christmas by giving back to the community and increasing our activities and efforts...

Infographics